Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Vascular Diseases × Antineoplastic Agents × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Neoplasms 2 Vascular Diseases 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Neoplasms, Second Primary 1 Metabolic Diseases 1 Heart Failure 1 Heart Diseases 1 Drug-Related Side Effects and Adverse Reactions 1 Colorectal Cancer Metastatic 1 Cardiotoxicity 1 Cancer Therapy-related Cardiovascular Toxicity 1 Breast Neoplasms 1 Advanced Ovarian Cancer 1

Interventions

Blood Specimen Collection 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03882580 2023-04-24

NEOCARDIO

Groupe Hospitalier Pitie-Salpetriere

Heart Diseases, Heart Failure, Metabolic Diseases, Vascular Diseases, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡